A high intake of yogurt has been found to be associated with a lower risk of developing type 2 diabetes, according to research published in open access journal BMC Medicine. This highlights the importance of having yogurt as part of a healthy diet.
Type 2 diabetes is a chronic condition that occurs when the body doesn't produce enough insulin, or the body's cells develop resistance to insulin. There is an increased risk of developing it if a relative has the condition or if an individual has an unhealthy lifestyle. Approximately 366 million people are affected by type 2 diabetes worldwide and it is estimated this will increase to 552 million people by 2030, which puts pressure on global healthcare systems.
Researchers from Harvard School of Public Health pooled the results of three prospective cohort studies that followed the medical history and lifestyle habits of health professionals. These studies were the Health Professionals' Follow-up Study (HFPS), which included 51,529 US male dentists, pharmacists, vets, osteopathic physicians and podiatrists, aged from 40 to 75 years; Nurses' Health Study (NHS), which began in 1976, and followed 121,700 female US nurses aged from 30 to 55 years; and Nurses' Health Study II (NHS II), which followed 116,671 female US nurses aged from 25 to 42 years beginning in the year 1989.
At the beginning of each cohort study, participants completed a questionnaire to gather baseline information on lifestyle and occurrence of chronic disease. Participants were then followed up every two years with a follow-up rate of more than 90 per cent. Participants were excluded if they had diabetes, cardiovascular disease or cancer at baseline. People were also excluded if they did not include any information about dairy consumption. This left a total of 41,497 participants from HPFS, 67,138 from NHS and 85,884 from NHS II.
Mu Chen, the study's lead author from Harvard School of Public Health, says: "Our study benefited from having such a large sample size, high rates of follow up and repeated assessment of dietary and lifestyle factors."
Within the three cohorts 15,156 cases of type 2 diabetes were identified during the follow-up period. The researchers found that the total dairy consumption had no association with the risk of developing type 2 diabetes. They then looked at consumption of individual dairy products, such as skimmed milk, cheese, whole milk and yogurt. When adjusting for chronic disease risk factors such as age and BMI as well as dietary factors, it was found that high consumption of yogurt was associated with a lower risk of developing type 2 diabetes.
The authors then conducted a meta-analysis, incorporating their results and other published studies, up to March 2013, that investigated the association between dairy products and type 2 diabetes. This found that consumption of one 28g serving of yogurt per day was associated with an 18 per cent lower risk of type 2 diabetes.
Previous research has suggested calcium, magnesium, or specific fatty acids present in dairy products may lower the risk of type 2 diabetes. It has been shown that probiotic bacteria found in yogurt improves fat profiles and antioxidant status in people with type 2 diabetes and the researchers suggest this could have a risk-lowering effect in developing the condition. To confirm this observation, and investigate whether or not yogurt is causal in the lowering of risk, randomized controlled trials are needed.
Senior researcher on the study Frank Hu, Harvard School of Public Health, says: "We found that higher intake of yogurt is associated with a reduced risk of type 2 diabetes, whereas other dairy foods and consumption of total dairy did not show this association. The consistent findings for yogurt suggest that it can be incorporated into a healthy dietary pattern."
T: +44 (0)20 3192 2243
M: +44 (0)78 2598 4543
Notes to Editor
Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
Mu Chen, Qi Sun, Edward Giovannucci, Dariush Mozaffarian, JoAnn E. Manson, Walter C. Willett and Frank B. Hu
BMC Medicine 2014, 12:215
For a copy of article during embargo please contact Shane Canning (firstname.lastname@example.org)
After embargo, article available at journal website here: http://www.biomedcentral.com/1741-7015/12/215
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. BMC Medicine is the flagship medical journal of the BMC series, publishing original research, commentaries and reviews that are either of significant interest to all areas of medicine and clinical practice, or provide key translational or clinical advances in a specific field.
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.